Progressive multifocal leukoencephalopathy in AIDS: Are there any MR findings useful to patient management and predictive of patient survival?

American Journal of Neuroradiology

Volumn 20, Issue 10, 1999, Pages 1896-1906

  Donovan Post, M Judith ^a   Yiannoutsos, Constantin ^b   Simpson, David ^c   Booss, John ^d   Clifford, David B ^e   Cohen, Bruce ^f   McArthur, Justin C ^g   Hall, Colin D ^h  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CYTARABINE; DIDANOSINE; NUCLEOSIDE DERIVATIVE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BRAIN ATROPHY; BRAIN VENTRICLE DILATATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMAGE ANALYSIS; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PROGNOSIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME;

ADULT; AIDS DEMENTIA COMPLEX; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; BIOPSY; BRAIN; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0344771116     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (89)

1. Hall CD, Dafini U, Simpson D, et al. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. N Engl J Med 1998; 338:1345-1351
2. Berger JR, Kaszovitz B, Post MJD, Dickinson G. Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. Ann Intern Med 1987;107:78-87
3. Krupp LB, Lipton RB, Swerdlow ML, Leeds NE, Llena J. Progressive multifocal leukoencephalopathy: clinical and radiographic features. Ann Neurol 1985;17:344-349
4. Petito CK, Cho ES, Lemann W, Navia BA, Price RW. Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. J Neuropathol Exp Neurol 1986;45:635-646
5. Levy RM, Bredesen DE, Rosenblum ML. Neurological manifestations of the acquired immune deficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg 1985;62:475-495
6. Berger JR, Moskovitz L, Fischl M, Kelley RE. The neurologic complications of AIDS: frequently the initial manifestation. Neurology 1984;:34(Suppl 1):134-135
7. Karahalios D, Breit R, Dal Conto MC, Levy RM. Progressive multifocal leukoencephalopathy in patients with HIV infection: lack of impact of early diagnosis by stereotactic brain biopsy. J Acquir Immune Defic Syndr Hum Retrovirol 1992;5: 1030-1038
8. Sweeney BJ, Miller RF, Harrison MJG. Progressive multifocal leukoencephalopathy. Br J Hasp Med 1993;50:187-192
9. Richardson EP Jr. Progressive multifocal leukoencephalopathy 30 years later. N Engl J Med 1988;318:315-317
10. Walker DL. Progressive multifocal leukoencephalopathy. In: Vinken PJ, Bruyn GW, Klawans HL, eds. Demyelinating Diseases: Handbook of Clinical Neurology. Amsterdam: Elsevier; 1985; 47:503-524
11. Brooks BR, Walker DL. Progressive multifocal leukoencephalopathy. Neurol Clin 1984;2:299-313
12. Portegies P, Algra PR, Hollak CEM, et al. Response to cytarabine in progressive multifocal leukoencephalopathy in AIDS. Lancet 1991;337:680-681
13. Conway B, Halliday WC, Brunham RC. Human immunodeficiency virus-associated progressive multifocal leukoencephalopathy: apparent response to 3-azido-3 deoxythymidine. Rev Infect Dis 1990;12:479-482
14. de Truchis P, Flament-Saillour M, Uetizberea J-A, Hassine D, Clair B. Inefficacy of cytarabine in progressive multifocal leukoencephalopathy in AIDS. Lancet 1993;342:622-623
15. Nicoli F, Chave B, Peragut JC, Gastaut JL. Efficacy of cytarabine in progressive multifocal leucoencephalopathy in AIDS. Lancet 1992;306:
16. Steiger MJ, Tarnesby G, Gable S, McLaughlin J, Schapira AH. Successful outcome of PML with cytarabine and Interferon. Ann Neurol 1993;33:407-411
17. Berger JR, Pall L, McArthur JG, et al. A pilot study of recombinant alpha 2A interferon in the treatment of AIDS-related progressive multifocal leukoencephalopathy (abstract). Neurology 1992;42(Suppl 3):257
18. Tashiro K, Doi S, Moriwaka F, Maruo Y, Nomura M. Progressive multifocal leukoencephalopathy with magnetic resonance imaging verification and therapeutic trials with interferon. J Neurol 1987;234:427-429
19. O'Riordan T, Daly PA, Hutchinson M, Shattock AG, Gardner SD. Progressive multifocal leukoencephalopathy: remission with cytarabine. J Infect 1990;20:51-54
20. Wolinsky JS, Johnson KP, Rand K, Merrigan TC. Progressive multifocal leukoencephalopathy: clinical pathological correlates and failure of a drug trial in two patients. Trans Am Neurol Assoc 1976;101:81-82
21. Garrels K, Kucharczyk W, Wortzman G, Shandling M. Progressive multifocal leukoencephalopathy: clinical and MR response to treatment AJNR Am J Neuroradiol 1996;17:597-600
22. Berger JR, Mucke L. Prolonged survival and partial recovery in AIDS-associated progressive multifocal leukoencephalopathy. Neurology 1988;38:1060-1065
23. Fong IW, Toma E, the Canadian PML Study Group. The natural history of progressive multifocal leukoencephalopathy in patients with AIDS. Clin Infect Dis 1995;20:1305-1310
24. Hedley-White ET, Smith BP, Tyler HR, Peterson WP. Multifocal leukoencephalopathy with remission and five-year survival. J Neuropathol Exp Neurol 1966;25:107-116
25. Lortholary O, Pialoux G, Dupont B, et al. Prolonged survival of a patient with AIDS and progressive multifocal leukoencephalopathy. Clin Infect Dis 1994;18:826-827
26. Chappel ET, Guthrie BL, Orenstein J. The role of stereotactic biopsy in the management of HIV-related focal brain lesions. Neurosurgery 1992;30:825-829
27. Silver SA, Arthur RR, Erozan YS, Sherman ME, McArthur JC, Uematsu S. Diagnosis of progressive multifocal leukoencephalopathy by stereotactic brain biopsy utilizing immunohistochemistry and the polymerase chain reaction. Acta Cytol 1995; 39:35-44
28. Levy RM, Rothholtz V. HIV-I-related neurologic disorders: neurosurgical implications in neuroimaging of AIDS II. Neuroimaging Clin N Am 1997;7:527-559
29. Weber T, Turner RW, Frye B, et al. Specific diagnosis of progressive multifocal leukoencephalopathy by polymerase chain reaction. J Infect Dis 1994;169:1138-1141
30. Moret H, Guichad M, Matherson S, et al. Virological diagnosis of progressive multifocal leukoencephalopathy: detection of JC virus DNA in cerebrospinal fluid and brain tissue of AIDS patients. J Clin Microbiol 1993;10:3313
31. McGuire D, Barhite S, Hollander H, et al. JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy. Ann Neurol 1995;37:395-399
32. Fong IW, Britton CB, Luinstra KE, et al. Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Clin Microbiol 1995;33:484-486
33. Weber T, Turner RW, Frye S, et al. Progressive multifocal leukoencephalopathy diagnosed by application of JC virus-specific DNA from cerebrospinal fluid. AIDS 1994;8:49-57
34. Brouqui P, Bollet C, Delmont J, Bourgeade A. Diagnosis of progressive multifocal leukoencephalopathy by PCR detection of JC virus from CSF. Lancet 1992;339:1182
35. Major EO, Ault GS. Progressive multifocal leukoencephalopathy: clinical and laboratory observations on a viral induced demyelinating disease in the immunodeficient patient. Curr Opin Neurol 1995;8:184-190
36. Elliott BC, Aromin I, Flanigan TP, Mileno M. Leukoencephalopathy with combined antiretroviral therapy (abstract). Intervent Conf AIDS 1996;11:222
37. Mileno M, Tashima K, Farrar D, et al. Resolution of AIDS-related opportunistic infections with addition of protease inhibitor treatment (abstract). In: Program and Abstracts of the Fourth Conference on Retrovirus and Opportunistic Infections. Washington, DC: January 22-26, 1997
38. Huang SS, Skolasky RL, Dal Pan GJ, Royal W III, McArthur J. Survival prolongation in HIV-associated progressive multifocal leukoencephalopathy treated with alpha-interferon: an observational study. J Neurovirol 1998;4:324-332
39. Clifford DB, the Neurologic AIDS Research Consortium. Natural history of progressive multifocal leukoencephalopathy (PML) in AIDS modified by anti-retroviral therapy (abstract). [Neuroscience of HIV infection. Basic Research and Clinical Frontiers, June 3-6, 1998; Chicago, IL] J Neurovirol 1998;7:346
40. Wheeler AL, Truwit CL, Kleinschmidt-DeMasters BK, Bryne WR, Hannon RN. Progressive multifocal leukoencephalopathy: contrast enhancement on CT scans and MR images. AJR Am J Roentgenol 1993;161:1049-1051
41. Guilleux M-H, Steiner RE, Young IR. MR imaging in progressive multifocal leukoencephalopathy. AJNK Am J Neuroradiol 1986;7:1033-1035
42. Mark AS, Atlas SW. Progressive multifocal leukoencephalopathy in patients with AIDS: appearance on MR images. Radiology 1989;173:517-620
43. Olsen WL, Longo FM, Mills CM, Norman D. White matter disease in AIDS: findings at MR imaging. Radiology 1988;169: 445-448
44. Ng S, Tse VC, Rubinstein J, Bradford E, Enzmann DR, Conley FK. Progressive multifocal leukoencephalopathy: unusual MR findings. J Comput Assist Tomogr 1995;19:302-305
45. Newton HB, Makley M, Slivka AP, et al. Progressive multifocal leukoencephalopathy presenting as multiple enhancing lesions on MRI: case report and literature review. J Neuroimaging 1995;5:125-128
46. Trotot PM, Vazeux R, Yamashita HK, et al. MRI pattern of progressive multifocal leukoencephalopathy (PML) in AIDS. J Neuroradiol 1990;17:233-254
47. Whiteman MLH, Post MJD, Berger JR, Tate LG, Bell MD, Limonte LP. Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathogenic correlation. Radiology 1993;187:233-240
48. Balakrishnan J, Becker PS, Kumar AJ, Zinreich SJ, McArthur JC, Bryan RN. Acquired immunodeficiency syndrome: correlation of radiologic and pathologic findings in the brain. Radiographics 1990;10:201-215
49. Sze G, Brant-Zawadzki MN, Norman D, Newton TH. The neuroradiology of AIDS. Semin Roentgenol 1987;22:42-53
50. Sarrazin JL, Soulie D, Derosier C, Lescop J, Schill H, Cordoliani YS. MRI patterns of progressive multifocal leukoencephalopathy. J Neuroradiol 1995;22:172-179
51. Lizerbram EK, Hesselink JR. Viral infections. Neuroimaging Clin N Am (Neuroimaging of AIDS I) 1997;7:261-280
52. Scatliff JH, Kwock L, Chancellor K, Bouldin TW, Kapoor CC, Castillo M. Postmortem MR imaging of the brains of patients with AIDS. Neuroimaging Clin N Am (Neuroimaging of AIDS I) 1997;7:297-320
53. Armand J-D, Dousset V, Viaud B, et al. HIV encephalitis and progressive multifocal leukoencephalopathy: a magnetization transfer study to differentiate pathologic processes. In: Proceedings of the 34th Annual Meeting of the American Society of Neuroradiology, Seattle, 1996. Oak Brook, IL; American Society of Neuroradiology, 1996:27
54. Dousset V, Armand J-P, Huot P, Viaud B, Caille J-M. Magnetization transfer imaging in AIDS-related brain diseases. Neuroimaging Clin N Am (Neuroimaging of AIDS II) 1997;7:447-460
55. Thurnher MM, Thurnher SA, Fleischmann D, et al. Comparison of T2-weighted and fluid-attenuated inversion-recovery fast spin-echo MR sequences in intracerebral AIDS-associated disease. AJNR Am J Neuroradiol 1997;18:1601-1609
56. Post MJD. Fluid-attenuated inversion-recovery fast spin-echo MR: a clinically useful tool in the evaluation of neurologically symptomatic HIV-positive patients. AJNR Am J Neuroradiol 1997;18:1611-1616
57. Chang L, Miller B, McBride D. et al. Brain lesions in patients with AIDS: H-1 MR spectroscopy. Radiology 1995;197:527
58. Chang L, Ernst T, Tornatore C, et al. Metabolic abnormalities in progressive multifocal leukoencephalopathy: a proton magnetic resonance spectroscopy study. Neurology 1997;48:836-845
59. Chang L, Ernst T. MR spectroscopy and diffusion-weighted MR imaging in focal brain lesions in AIDS. Neuroimaging Clin N Am (Neuroimaging of AIDS II) 1997;7:409-426
60. Miller JR, Barrett RE, Britton CB, et al. Progressive multifocal leukoencephalopathy in a male homosexual with T cell immunodeficiency. N Engl J Med 1982;307:1436-1438
61. Blum LM, Chambers RA, Schwartzman RJ, Streletz LJ. Progressive multifocal leukoencephalopathy in acquired immune deficiency syndrome. Arch Neurol 1985;42:137-139
62. Astrom K-E, Mancall EL, Richardson EP Jr. Progressive multifocal leukoencephalopathy: a hitherto unrecognized complication of chronic lymphatic leukemia and Hodgkin's disease. Brain 1958;81:93-111
63. Zu Rhein GM, Chou S-M. Particles resembling papova viruses in human cerebral demyelinating disease. Science 1965;148: 1477-1479
64. Silverman L, Rubinstein LJ. Electron microscopic observation in a case of progressive multifocal leukoencephalopathy. Acta Neuropathol (Berlin) 1965;5:215-224
65. Padgett BL, Walker DL, Zurhein GM, Echroade RJ, Dessel BH. Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet 1971;1:1251-1260
66. Bernick C, Gregorios JB. Progressive multifocal leukoencephalopathy in a patient with acquired immunodeficiency syndrome. Arch Neurol 1984;41:780-783
67. Aksamit A, Gendelman H, Orenstein J, Pezeshkpou RG. AIDS-associated progressive multifocal leukoencephalopathy (PML): comparison to non-AIDS PML with in situ hybridization and immunohistochemistry. Neurology 1990;40:1073-1078
68. Vazeux R, Cumont M, Girard P, et al. Severe encephalitis resulting from co-infection with HIV and JC virus. Neurology 1990;40:944-948
69. Berger JR, Concha M. Progressive multifocal leukoencephalopathy: the evaluation of a disease once considered rare. J Neurovirol 1995;1:5-18
70. Budka H. Neuropathology of myelitis, myelopathy and spinal infections in AIDS. Neuroimaging Clin N Am (Neuroimaging of AIDS II) 1997;7:639-650
71. Berger JR, Levy RM, Flomenhoft D, Dobbs M. Predictive factors for prolonged survival in AIDS: associated PML. J Neurovirol 1998;4:342
72. Wright D, Schneider A, Berger JR. Central nervous system opportunistic infections. Neuroimaging Clin N Am (Neuroimaging of AIDS II) 1997;7:513-525
73. Henry K, Worley J, Sullivan C, et al. Documented improvement in late stage manifestations of AIDS after starting ritonavir in combination with two reverse transcriptase inhibitors (abstract). Opportun Infec 1997; Jan 22;26:130
74. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1988;338:853-860
75. Esiri M, Kennedy P. Viral diseases. In: Adams JH, Duchen LW, eds. Greenfield's Neuropathology. 5th ed. London: Edward Arnsel; 1992:367-370
76. Post MJD, Tate LG, Quencer RM, et al. CT, MR and pathology in HIV encephalitis and meningitis. AJNR Am J Neuroradiol 1988;9:469-476
77. Post MJD, Berger JR, Duncan R, et al. Asymptomatic and neurologically symptomatic HIV-seropositive subjects: results of long term MR imaging and clinical follow-up. Radiology 1993; 188:727-733
78. Chrysikopoulos HS, Press GA, Grafe MR, Hesselink JR, Wiley CA. Encephalitis caused by human immunodeficiency virus: CT and MR imaging manifestations with clinical and pathologic correlation. Radiology 1990;175:185-191
79. Post MJD, Sheldon JJ, Hensley GT, et al. Central nervous system disease in acquired immunodeficiency syndrome: prospective correlation using CT, MRI and pathologic studies. Radiology 1986;158:141-148
80. Ramsey RG, Geremia GK. CNS complications of AIDS: CT and MR findings. AJR Am J Roentgenol 1988:151:449-454
81. Ledoux S, Libman I, Robert F, Just N. Progressive multifocal leukoencephalopathy with gray matter involvement. Can J Neurol Sci 1989;16:200-202
82. Cunningham ME, Kishore PRS, Rengachary SS, Preskorn S. Progressive multifocal leukoencephalopathy presenting as focal mass lesion in the brain. Surg Neurol 1997;8:448-450
83. Vanneste JAL, Bellot SM, Stam FC. Progressive multifocal leukoencephalopathy presenting as a single mass lesion. Eur Neurol 1984;23:113-118
84. Carroll BA, Lane B, Norman D, Enzmann D. Diagnosis of progressive multifocal leukoencephalopathy by computed tomography. Radiology 1977;122:137-141
85. Tuite M, Keetonen L, Kieburtz K, Handy B. Efficacy of gadolinium in MR brain imaging of HIV-infected patients. AJNR Am J Neuroradiol 1993;14:257-263
86. Heinz ER, Drayer BP, Haeinggell CA, Painter MJ, Crumrine P. Computed tomography in white matter disease. Radiology 1979;130:371-378
87. Al-Sahi R, Sadler M, Davies, E, Nelson MR, Gazzard BG. Progressive multifocal leukoencephalopathy (PML) treatment with cidofovir. Presented at the 12th World AIDS Conference, June 28-July 3, 1998, Geneva, Switzerland
88. Acosta A. Regression or stabilization of PML by highly active antiretroviral therapy (HAART) and acyclovir therapy. Presented at the 12th World AIDS Conference, June 28-July 3, 1998, Geneva, Switzerland
89. Fichtenbaum CJ, Tantisiviwan W, Tebas P, Clifford DB, Powderly WG, Fichtenbaum CJ. The occurrence of progressive multifocal leukoencephalopathy (PML) in HIV infected persons taking highly active antiretroviral therapy (HAART). Presented at the 12th World AIDS Conference, June 28-July 3, 1998, Geneva Switzerland